Senate Finance leaders in talks on deal to limit drug price increases - (The Hill via NewsPoints Desk)

  • According to sources familiar with the negotiations, leaders of the US Senate Finance Committee are holding bipartisan discussions on a potential deal to limit drug price increases in Medicare, reported The Hill.

  • One proposal is to require that drugmakers pay back rebates to Medicare's Part D prescription drug program if their prices rise faster than inflation.

  • Another measure would force pharmaceutical firms to pay money back to Medicare if they launch a new drug with a high price.

  • However, some lawmakers are pushing back on the idea, arguing it comes too close to price controls for drugs, which Republicans have long opposed, the news source said.

To read more NewsPoints articles, click here.